The 12-month characteristics of safety lacked hypoglycemia and palpitations, but included a few gastrointestinal ARs, which were, respectively, five episodes of nausea in the GLP-1 RA group and two cases of urinary tract infections in the SGLT-2i group, as seen in Table 5. This evidence concerns the gene GLP1R and Hypoglycemia.